Detalles de la búsqueda
1.
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).
Target Oncol;
19(3): 423-433, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38613731
2.
Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer.
J Immunother Cancer;
12(2)2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38360040
3.
Effect of litter removal five years after the Fukushima accident on 137Cs uptake by Japanese cedar.
J Environ Radioact;
273: 107390, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38295586
4.
Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.
JAMA Oncol;
10(3): 315-324, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38127362
5.
A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L).
JTO Clin Res Rep;
4(12): 100587, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38046380
6.
Variability in radiocesium activity concentration in growing hardwood shoots in Fukushima, Japan.
PLoS One;
18(12): e0293166, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38064418
7.
Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.
JAMA Netw Open;
6(12): e2347700, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100106
8.
Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer.
Sci Rep;
13(1): 19729, 2023 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957228
9.
Docetaxel Plus Ramucirumab With Primary Prophylactic Pegylated Granulocyte-Colony Stimulating Factor Support for Elderly Patients With Advanced NSCLC: A Multicenter Prospective Single Arm Phase 2 Trial: DRAGON Study (WJOG9416L).
JTO Clin Res Rep;
4(10): 100569, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37822699
10.
Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: treatment rationale and protocol design of the B-DASH study (WJOG 14720 L).
BMC Cancer;
23(1): 902, 2023 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37749521
11.
Effectiveness and Safety of Atezolizumab Monotherapy in Previously Treated Japanese Patients With Unresectable Advanced or Recurrent NSCLC: A Multicenter, Prospective, Observational Study (J-TAIL).
JTO Clin Res Rep;
4(3): 100484, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37034464
12.
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer.
Sci Rep;
13(1): 3698, 2023 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36878936
13.
Real-world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK-positive non-small-cell lung cancer.
Cancer Sci;
114(6): 2560-2568, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36866958
14.
Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility.
JAMA Netw Open;
6(2): e230698, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36826813
15.
Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial.
BMC Cancer;
23(1): 6, 2023 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36597021
16.
Immune thrombocytopenia in a small cell lung cancer patient treated with atezolizumab: a case report.
Transl Lung Cancer Res;
11(11): 2346-2355, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36519029
17.
Pharmacotherapy for Advanced Non-Small Cell Lung Cancer with Performance Status 2 without Druggable Gene Alterations: Could Immune Checkpoint Inhibitors Be a Game Changer?
Cancers (Basel);
14(19)2022 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36230785
18.
Publisher Correction: Distinguishing externally from saccade-induced motion in visual cortex.
Nature;
611(7934): E5, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36241716
19.
Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: Analysis of Safety and Efficacy for Patients With Renal Impairment.
Clin Lung Cancer;
23(7): 585-592, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36114096
20.
Distinguishing externally from saccade-induced motion in visual cortex.
Nature;
610(7930): 135-142, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36104560